A phase I single-center, randomized, double-blind, placebo-controlled, dose-escalation, single-center trial to determine tolerability, safety, pharmacokinetics and pharmacodynamics of a single oral dose of HWH486 in healthy adults
Latest Information Update: 08 Aug 2025
At a glance
- Drugs HWH 486 (Primary)
- Indications Chronic urticaria; Urticaria
- Focus Pharmacokinetics
Most Recent Events
- 08 Aug 2025 New trial record